期刊文献+

冠状动脉病变程度与血清胱抑素、一氧化氮及超氧化物歧化酶水平的相关性研究 被引量:4

Study on the Relationship between Severity of Coronary Artery Lesion and the Level Cystatin C, Nitric Oxide and Superoxide Dismutase of Serum
下载PDF
导出
摘要 目的:通过检测冠状动脉病变患者的血清胱抑素(cystatin C,CyC)、一氧化氮(nitric oxide,NO)及超氧化物歧化酶(superoxide dismutase,SOD)水平,探讨三者与冠状动脉粥样硬化程度的相互关系,从而评价三者对冠心病的临床诊断价值。方法经冠状动脉造影证实冠状动脉没有明显狭窄入选造影正常组,共40例;有一支血管狭窄入选单支病变组,共44例;有两支血管狭窄入选双支病变组,共43例;有大于两支血管狭窄入选多支病变组,共35例。对四组分别进行血清CyC,NO,SOD及超敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)水平检测。结果造影正常组、单支病变组、双支病变组、多支病变组的CyC和hs-CRP水平依次呈递增趋势;NO和SOD浓度水平依次呈递减趋势,四组之间差异有统计学意义(P<0.05)。冠状动脉 Gensini积分与血清CyC和 hs-CRP水平呈正相关,相关系数分别为0.473,0.429;与NO和 SOD水平呈负相关,相关系数分别为-0.356,-0.384。血清CyC与 hs-CRP水平呈正相关,与 NO和 SOD水平呈负相关,相关系数分别为0.458,-0,426,-0.484(P<0.05)。结论随着冠状动脉病变程度的增加,CyC浓度升高,NO和 SOD减少,引起血管内皮功能障碍,导致冠状动脉发生病变及加重。CyC,NO和 SOD可作为冠心病的辅助诊断指标。 Objective To study the correlation between coronary lesion and Cystatin C (CyC),Nitric Oxide (NO)and Super oxide dismutase,accumulate the clinical experience in prevention and diagnose of Coronary Heart Disease (CHD)by analyzing the contents of serum Cystatin C (CyC),Nitric Oxide and Superoxide Dismutase in patients with coronary lesion.Meth-ods According to their severity of coronary artery lesion,all cases were divided into four groups:Normal compared group (40 cases);Simple branch pathological group (44 cases);Double branch pathological group (43 cases):Multi-branch patho-logical group (35 cases).All cases were tested CyC,NO,SOD and hs-CRP in serum.Results The level of CyC and hs-CRP were increased gradually from normal group to multi-branch group.The level of NO and SOD were decreased gradually from normal group to multi-branch group.There were significant differences the levels of CyC,NO,SOD and hs-CRP among the four groups.Coronary lesion Gensini in the CHD patients had significant positive relationship to the level of CyC or hs-CRP respectively (r=0.473,0.429),had significant negative relationship to the level of NO or SOD respectively (r=-0.356, 0.384)(P〈0.05).CyC in the CHD patients had significant positive relationship to the level of hs-CRP (r=0.458),had sig-nificant negative relationship to the level of NO or SOD respectively (r=-0.426,0.484,P〈0.05).Conclusion By aggravation of coronary artery lesion,the level of CyC increased,reduced the contents of NO,SOD,aroused endothelial dysfunc-tion,induced occurrence and aggravation of coronary artery lesion.CyC,NO and SOD play important mark in the assistant diagnosis of the disease.
出处 《现代检验医学杂志》 CAS 2015年第1期82-84,87,共4页 Journal of Modern Laboratory Medicine
基金 武汉市卫生局临床医学科研项目,编号:WX11B14.
关键词 胱抑素C 一氧化氮 超氧化物歧化酶 冠状动脉病变 CyC NO SOD coronary artery lesion
  • 相关文献

参考文献10

  • 1Koenig W, Twardella D, Brenner H, et al. Plasma co- ncentrations of cystatin C in patientswith coronary heart disease and risk for secondary cardiovascular e- vents:more than simply a marker of glomerular filtra- tion rate[J]. Clin Chem, 2005,51 ( 2 ): 321-327.
  • 2Arpegard J, Ostergren J, de Faire U, et al. Cystatin C- a marker of peripher alatherosclerotie disease? [J]. Atherosclerosis, 2008,199(2): 397-401.
  • 3Ix J H, Shlipak MG, Chertow GM, et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study[J]. Circulation, 2007,115 (2) :173-179.
  • 4贺涛,唐艺加,李刚,陶剑虹,刘明江.胱抑素C水平与冠心病的相关性研究[J].中华老年心脑血管病杂志,2012,14(3):264-267. 被引量:24
  • 5蒋云华,王金良.血浆胱抑素C浓度与非慢性肾病冠心病患者冠状动脉病变严重程度的相关性[J].现代检验医学杂志,2011,26(4):42-44. 被引量:1
  • 6陈晨,吴海云,陈杰,白静,尚晨黧,刘丽凤,王禹.胱抑素C对冠心病的诊断价值及其影响因素[J].中国循证心血管医学杂志,2013,5(2):145-147. 被引量:15
  • 7Niccoli G, Conte M,Della Bona R, et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtra- tion rate[J]. Atherosclerosis, 2008,198 (2) : 373-380.
  • 8Kiyosue A, Hirata Y, Ando J, et al. Plasma Cystatin C concentration renects the severity of coronary artery disease in patients without chronic kidney disease[J]. Circ J,2010,74(11) :2441-2447.
  • 9方小丽,王圣,马建林,李爱吟.血浆NO水平与冠脉病变稳定性的相关性研究[J].海南医学,2012,23(18):18-19. 被引量:3
  • 10马建林,王圣,李新明,苏哲坦,李斌,陈关良,王卫,林劲,张敬文,吴忠.冠心病患者内皮功能与血清SOD、丙二醛含量相关[J].心脏杂志,2006,18(3):320-322. 被引量:13

二级参考文献46

  • 1俸家富,罗军,李少林.胱抑素C——肾小球滤过率肌酐替代标记物[J].国外医学(临床生物化学与检验学分册),2005,26(3):168-172. 被引量:112
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:702
  • 3Schrier RW. Role of diminished renal function in car- diovascular mortality : marker or pathogenetic factor [J]. Am Coll Cardiol,2006,47(1) : 1-8.
  • 4Anavekar NS,Mc Murray JV,Velaquez EJ,et al. Re- lation between renal dysfunction and cardiovascular outcomes after myocardial infarction [J]. N Engl J Med, 2004,351 (13) : 1285-1295.
  • 5Wang J,Sim AS,Wang XL,et al. Relations between markers of renal function,coronary risk factors and the occurrence and severity of artery sclerosis[J]. J Cardiol, 2008,197 (2) : 853-859.
  • 6Sekizuka H, Akashi YJ, Kawasaki K, et al. Cystatin C:A better marker to detect coronary artery sclero- sis [J]. J Cardiol, 2009,54 (3): 359-367.
  • 7Ichimoto E,Jo K,Kobayashi Y,et al. Prognostic sig- nificance of cystatin C in patients with ST-elevation myocardial infarction [J ]. Circ J, 2009,73 ( 9 ) : 1669- 1673.
  • 8Kato K, Sato N, Yamamoto T, et al. Valuabte mark- ers for contrast-induced nephropathy in patients un- dergoing cardiac catheterization [J]. Circ J, 2008, 72 (9) : 1499-1505.
  • 9Niccoli G,Conte M,Della Bona R,et al. Cystatin C is associated with an increased coronary atheroscle- rotic burden and a stable plaque phenotype in pa- tients with ischemie heart disease and normal glomerular filtration rate[J]. Atherosclerosis, 2008, 198(2) : 373-380.
  • 10Arihiro Kiyosue, Yasunobu Hirata, Jiro Ando, et al. Plasma Cystatin C concentration reflects the severi- ty of coronary artery disease in patients without chronic kidney disease [J]. Cite J, 2010, 74 (11) : 2441-2447.

共引文献48

同被引文献41

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部